Evidence map›Paper›PMID 30014831›Full record

ArticleEmerging infectious diseases2018

Brucellosis in Dogs and Public Health Risk.

Martha E Hensel, Maria Negron, Angela M Arenas-Gamboa

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed.

  1. One health (Amsterdam, Netherlands) · 2026
    Review
  2. Pathogens (Basel, Switzerland) · 2026
    Review
  3. Review
  4. Brucellosis Surveillance - United States, 2010-2024.Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002) · 2026
    Article
  5. Article
  6. Risk Assessment and Management of Brucella canis Introduction via Commercial Dog Imports Into France.Risk analysis : an official publication of the Society for Risk Analysis · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Absence ofEpidemiologia (Basel, Switzerland) · 2025
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Performance characteristics of threeFrontiers in veterinary science · 2025
    Article
  19. Article
  20. A first insight into seropositivity and risk factors forOne health (Amsterdam, Netherlands) · 2024
    Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Martha E Hensel
Maria Negron
Angela M Arenas-Gamboa

Funding

Comparative Biomedical Research Training for VeterinariansT32OD011083 · OD · TEXAS A&M AGRILIFE RESEARCH · PI ALBERT MULENGA · 2012 to 2026
$4.8M
NIH HHS T32 OD011083
6 · The paper itself

Abstract

Brucella canis infects dogs and humans. In dogs, it can cause reproductive failure; in humans, it can cause fever, chills, malaise, peripheral lymphadenomegaly, and splenomegaly. B. canis infection in dogs is underrecognized. After evaluating serologic data, transmission patterns, and regulations in the context of brucellosis in dogs as an underrecognized zoonosis, we concluded that brucellosis in dogs remains endemic to many parts of the world and will probably remain a threat to human health and animal welfare unless stronger intervention measures are implemented. A first step for limiting disease spread would be implementation of mandatory testing of dogs before interstate or international movement.

Indexed as

Brucella canisPublic HealthAnimalsAntibodies, ProtozoanBrucellosisDog DiseasesDogsGlobal HealthHumansSensitivity and SpecificityZoonosesAntibodies, ProtozoanbacteriaBrucella canisbrucellosisdogspublic healthserologyzoonoses

Identifiers

PMID30014831
PMCPMC6056133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.